Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3350019
Max Phase: Preclinical
Molecular Formula: C39H66N10O11
Molecular Weight: 851.02
Molecule Type: Small molecule
Associated Items:
ID: ALA3350019
Max Phase: Preclinical
Molecular Formula: C39H66N10O11
Molecular Weight: 851.02
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)CCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(N)=O
Standard InChI: InChI=1S/C39H66N10O11/c1-21(2)16-27(44-32(53)13-15-41)37(58)47-29(18-24-9-11-25(52)12-10-24)36(57)43-23(5)34(55)49-31(20-51)39(60)45-26(8-6-7-14-40)35(56)46-28(17-22(3)4)38(59)48-30(19-50)33(42)54/h9-12,21-23,26-31,50-52H,6-8,13-20,40-41H2,1-5H3,(H2,42,54)(H,43,57)(H,44,53)(H,45,60)(H,46,56)(H,47,58)(H,48,59)(H,49,55)/t23-,26-,27-,28-,29-,30-,31-/m0/s1
Standard InChI Key: DPCDDMUDJHWDFX-VGPFALITSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 851.02 | Molecular Weight (Monoisotopic): 850.4913 | AlogP: -3.61 | #Rotatable Bonds: 28 |
Polar Surface Area: 359.52 | Molecular Species: BASE | HBA: 13 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.57 | CX Basic pKa: 10.19 | CX LogP: -4.73 | CX LogD: -8.02 |
Aromatic Rings: 1 | Heavy Atoms: 60 | QED Weighted: 0.04 | Np Likeness Score: 0.16 |
1. Nagarajan SR, Devadas B, Zupec ME, Freeman SK, Brown DL, Lu HF, Mehta PP, Kishore NS, McWherter CA, Getman DP, Gordon JI, Sikorski JA.. (1997) Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase., 40 (10): [PMID:9154965] [10.1021/jm9608671] |
Source(1):